David Cartmell explains how our new protein A resin, DurA Cycle, helps to reduce the cost of goods for commercial processes. Find out how this innovation can make medicines more affordable for #pharmaceutical companies and end patients. 💊
Ecolab, Purolite Resins’ Post
More Relevant Posts
-
Curious about how to implement Real-Time Monitoring? 💡Check out our Industry Insight to understand how you can make more of this opportunity for process efficiency in the bio/pharmaceutical industry. 🚀 👉 https://lnkd.in/dNzJkMH4
To view or add a comment, sign in
-
Great article from McKinsey highlighting the value of a unified data platform approach to consolidate data sets and enable predictive analytics and increase R&D velocity.
Productivity in biopharmaceutical R&D has slumped for a decade or more. 📉 For this new article, we spoke with hundreds of biopharma R&D leaders and drew on their own experience to help create a recipe for sustainable, value-creating innovation— even in the face of strengthening industry headwinds— to help make more medicines that matter to patients. Check it out here: https://lnkd.in/ey98YWCz #medicine #pharmaceuticals #research
To view or add a comment, sign in
-
Key Opinion Leaders (KOL) are crucial in #raredisease studies. The challenge is how to use KOLs most effectively. Angela Vinken and Patti Arsenault discuss how KOLs can shape #clinicaltrials, best practices, and key considerations: https://bit.ly/3wBCLpe #biotech #pharma #pharmaceutical #pharmaceuticalindustry #regulatory #regulatoryaffairs #FDA #rarediseases #clinicaldevelopment #drugdevelopment
To view or add a comment, sign in
-
Thanks Brandon Parry for sharing this insightful article, I forwarded to my leadership team. The discussion on the challenges and opportunities in biopharma R&D productivity strongly resonates with us at L7 Informatics. We recognize that to truly boost R&D performance, the industry must address the fragmentation caused by point solutions, disparate data sources, and paper-based processes. Our unified platform, L7|ESP, is designed to tackle these issues by providing seamless integration and AI-ready data, enabling our partners to maximize the value of their AI/ML investments. By partnering with some incredible folks at top-performing biopharma R&D organizations, we are creating a streamlined, interoperable pathways that drive digital transformation and unlock deeper insights. #pharmaceutical #research #R&D #L7|ESP
Productivity in biopharmaceutical R&D has slumped for a decade or more. 📉 For this new article, we spoke with hundreds of biopharma R&D leaders and drew on their own experience to help create a recipe for sustainable, value-creating innovation— even in the face of strengthening industry headwinds— to help make more medicines that matter to patients. Check it out here: https://lnkd.in/ey98YWCz #medicine #pharmaceuticals #research
To view or add a comment, sign in
-
the first episode in series of crystallization focused topics on the scientific background and practical use of our Crystallization Devices!
In the coming weeks, we will dive into the concept of API crystallization through a new series titled '𝗧𝗮𝗰𝗸𝗹𝗶𝗻𝗴 𝘁𝗵𝗲 𝗔𝗣𝗜 𝗖𝗿𝘆𝘀𝘁𝗮𝗹𝗹𝗶𝘇𝗮𝘁𝗶𝗼𝗻 𝗖𝗵𝗮𝗹𝗹𝗲𝗻𝗴𝗲𝘀'. This series will cover key fundamentals, address industry challenges, and highlight the crucial role of crystallization in transforming #API substances into drug products. 𝗘𝗽𝗶𝘀𝗼𝗱𝗲 𝟭: What is API crystallization, why is it crucial, and what challenges does the #pharmaceutical industry face in turning API substances into drug products? Read also our blog article: https://lnkd.in/e3M_pw2e
To view or add a comment, sign in
-
In the coming weeks, we will dive into the concept of API crystallization through a new series titled '𝗧𝗮𝗰𝗸𝗹𝗶𝗻𝗴 𝘁𝗵𝗲 𝗔𝗣𝗜 𝗖𝗿𝘆𝘀𝘁𝗮𝗹𝗹𝗶𝘇𝗮𝘁𝗶𝗼𝗻 𝗖𝗵𝗮𝗹𝗹𝗲𝗻𝗴𝗲𝘀'. This series will cover key fundamentals, address industry challenges, and highlight the crucial role of crystallization in transforming #API substances into drug products. 𝗘𝗽𝗶𝘀𝗼𝗱𝗲 𝟭: What is API crystallization, why is it crucial, and what challenges does the #pharmaceutical industry face in turning API substances into drug products? Read also our blog article: https://lnkd.in/e3M_pw2e
To view or add a comment, sign in
-
An evolving payer and commercial landscape #postCOVID19 pandemic, increasing #regulatory complexity, and the discovery of new treatments with smaller patient populations are all factors impacting the research, development, and launch of new #pharmaceutical products🖋️Andy Studna https://lnkd.in/gaWdDibV #clinicaltrials #clinicalresearch
To view or add a comment, sign in
-
Would you like to understand patient illnesses and conditions with greater accuracy? Would you like to find out how to track patient symptoms with minimal impact on their day? Join Richard Heath at the EPHMRA Conference at 9:10am on Thursday 27th June in London to find out how! To see his talk in-person, see link in comments to register. 👇 #Pharmaceutical #Conference #MarketResearch #MRX
To view or add a comment, sign in
-
Curious to see our eMed BV solution in action? Check out our latest case study for a look into real results and learn how seeQer is revolutionizing the specialty #pharmaceutical space. Read more: https://lnkd.in/eXGCHhhy
To view or add a comment, sign in
-
Happy Shivratri 2024 Discover the top 5 groundbreaking innovations from Delhi's premier pharma leader, RK Lifecare Inc, setting new standards in healthcare for 2024. #pharmacy #pharmaceutical #shivratri2024 #shivratri
To view or add a comment, sign in
28,701 followers